<!doctype html>
<html lang="en">

<head>
  <!-- Required meta tags -->
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

  <!-- Bootstrap CSS -->
  <link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.5.0/css/bootstrap.min.css" integrity="sha384-9aIt2nRpC12Uk9gS9baDl411NQApFmC26EwAOH8WgZl5MYYxFfc+NcPb1dKGj7Sk" crossorigin="anonymous">

  <!-- Other CSS -->
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">
  <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Open+Sans:ital,wght@0,300;0,400;0,600;0,700;0,800;1,300;1,400;1,600;1,700;1,800&display=swap">
  <link rel="stylesheet" href="bchu.css">
  <link rel="icon" href="images/penn-favicon.png" type="image/x-icon">
  <title>Abdominal Infections</title>
</head>


<body>

  <header class="header-penn">
    <!-- NAVBAR -->
    <nav class="navbar navbar-expand-lg navbar-dark navbar-penn">
      <a class="navbar-brand logo-penn" href="#">
        <img src="images/penn-shield.png" width="30" height="30" class="d-inline-block align-center">
        Antimicrobial Stewardship
      </a>
      <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation">
        <span class="navbar-toggler-icon"></span>
      </button>
      <div class="collapse navbar-collapse" id="navbarNav">
        <ul class="navbar-nav">
          <li class="nav-item">
            <a class="nav-link" href="#">Home <span class="sr-only">(current)</span></a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="#">Microbiology (Bugdrug)</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="#">ID Transition Service (IDTS)</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="#">Infection Control</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="#">Education</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="#">Contact Us</a>
          </li>
        </ul>
      </div>
    </nav>

  </header>

  <div class="container site-content">
    <div class="row">

      <!-- aside for SIDEBAR -->
      <aside class="col-12 col-lg-3">
        <div class="nav-div-penn">
          <nav class="nav flex-column nav-penn">
            <a class="nav-link" href="#">ilum</a>
            <a class="nav-link" href="#">Antibiotic Approval</a>
            <div class="dropdown">
              <a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#" role="button" aria-haspopup="true" aria-expanded="false">Treatment Guidelines</a>
              <div class="dropdown-menu" aria-labelledby="dropdownMenuLink">
                <a class="dropdown-item" href="#">Abdominal Infections</a>
                <a class="dropdown-item" href="#">Bone and Joint Infections</a>
                <a class="dropdown-item" href="#">Candida Empiric Treatment Guidelines</a>
                <a class="dropdown-item" href="#">Central Nervous System Infections</a>
                <a class="dropdown-item" href="#">COVID-19 Infection</a>
                <a class="dropdown-item" href="#">Endocarditis</a>
                <a class="dropdown-item" href="#">Gastroenteritis</a>
                <a class="dropdown-item" href="#">Genitourinary Infections</a>
                <a class="dropdown-item" href="#">Gynecologic and Obstetrics Guidelines</a>
                <a class="dropdown-item" href="#">Neutropenic Fever</a>
                <a class="dropdown-item" href="#">Respiratory Tract Infections</a>
                <a class="dropdown-item" href="#">Sepsis</a>
                <a class="dropdown-item" href="#">Skin and Soft Tissue</a>
              </div>
            </div>
            <a class="nav-link" href="#">Prophylaxis Guidelines</a>
            <a class="nav-link" href="#">Antimicrobial Dosing</a>
            <a class="nav-link" href="#">Antimicrobial Information</a>
            <a class="nav-link" href="#">Antimicrobial Formulary</a>
          </nav>
        </div>
      </aside>

      <!-- article contains the accordion, CSS means 12 mobile, 9 when lg -->
      <article class="col-12 col-lg-9">
        <h1>Abdominal Infection Guidelines</h1>

        <!-- accordion -->
        <div class="accordion" id="abdominal">
          <div class="card">
            <div class="card-header" id="headingOne">
              <h2 class="mb-0">
                <button class="btn btn-link btn-penn" type="button" data-toggle="collapse" data-target="#collapseOne" aria-expanded="true" aria-controls="collapseOne"><i class="fa fa-plus"></i>
                  Intra-abdominal infection
                </button>
              </h2>
            </div>
            <!--  To show by default, add "show" to the class of id=collapseOne  -->
            <div id="collapseOne" class="collapse" aria-labelledby="headingOne" data-parent="">
              <div class="card-body">

                <p>Antimicrobial dosing is based on a patient with normal renal function. For dosing based on impaired renal function, see <a href="#">Dosing of Antimicrobial Agents</a>.</p>
                <p>An appropriate source control procedure to drain infected foci, control ongoing peritoneal contamination by diversion or resection, and restore anatomic and physiological function to the extent feasible is recommended for nearly all patients with intra-abdominal infection.</p>
                <p>The following recommendations are empiric guidelines. Base definitive choice of antimicrobial agents on operative cultures and susceptibility test results.</p>
                <p>These guidelines may not be appropriate in patients with history of colonization or infection with resistant organisms or recent antimicrobial exposure. For these patients, consider Infectious Diseases consultation.</p>

                <table class="table table-bordered table-sm table-responsive table-penn">
                  <thead class="thead-dark">
                    <tr>
                      <th scope="col">Setting</th>
                      <th scope="col">Preferred Therapy</th>
                      <th scope="col">&beta;-Lactam Allergy</th>
                      <th scope="col">Antifungal Therapy</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr class="tr-penn">
                      <td colspan="4"><strong>Community-Acquired</strong> <br>
                        Hospitalized &lt; 48 hrs <br>
                        <i>Enterobacteriaceae,
                          Streptococcus spp.,
                          Anaerobes </i></td>
                    </tr>
                    <tr>
                      <th scope="row">Low risk/severity</th>
                      <td>Ceftriaxone 1 gram IV daily <b>AND</b> Metronidazole 500 mcg PO Q12H <br><b>Alternative: </b>Ampicillin/sulbactam 1.5 grams IV Q6H</td>
                      <td>Levofloxacin 750 mg IV/PO daily <b>AND</b> Metronidazole 500 mg PO Q12H</td>
                      <td rowspan="2">Start fluconazole 400 mg PO daily only if Candida grows from cultures. Base definitive antifungal choice on susceptibility.</td>
                    </tr>
                    <tr>
                      <th scope="row">High risk <br><i>Adv. age, immuno-compromised<sup>1</sup></i></th>
                      <td>Cefepime 1 gram IV Q8H <b>AND</b> Metronidazole 500 mg IV/PO Q12H <br> <b>Alternative:</b> Piperacillin-tazobactam 4.5 grams IV Q8H</td>
                      <td>Levofloxacin 750 mg IV/PO daily <b>AND</b> Metronidazole 500 mg PO Q12H</td>
                    </tr>
                    <tr>
                      <th scope="row">High severity <br> <i>Sepsis/septic shock</i></th>
                      <td colspan="3"><a href="#">See sepsis/septic shock guidelines</a></td>
                    </tr>
                    <tr class="tr-penn">
                      <td colspan="4"><strong>Healthcare-Associated</strong> <br> Hospitalized ≥ 48 hrs, Post-operative <br>
                        <i>P. aeruginosa,
                          Enterobacteriaceae,
                          S. aureus,
                          Enterococcus spp.,
                          Anaerobes +/-
                          Candida spp.</i></td>
                    </tr>
                    <tr>
                      <th scope="row">Mild to moderate severity</th>
                      <td>Cefepime 1 gram IV Q8H <b>AND</b> Metronidazole 500 mg PO Q12H <b>AND</b> Vancomycin IV (<a href="#">dosing</a>) <br>
                        <b>Alternative:</b>
                        Piperacillin/tazobactam 4.5 grams IV Q8H <b>AND</b> Vancomycin IV (<a href="#">dosing</a>)
                      </td>
                      <td>Levofloxacin 750 mg IV/PO daily <b>AND</b> Metronidazole 500 mg PO Q12H <b>AND</b> Vancomycin IV (<a href="#">dosing</a>) </td>
                      <td>Start fluconazole 400 mg PO daily only if Candida grows from cultures. Base definitive antifungal choice on susceptibility.</td>
                    </tr>
                    <tr>
                      <th scope="row">High severity <i>Sepsis/septic shock</i></th>
                      <td colspan="3"><a href="#">
                          See sepsis/septic shock guidelines</a></td>
                    </tr>
                  </tbody>
                </table>
                <span class="table-subtext"><sup>1</sup>For patients with neutropenia, refer to the <a href="#">Neutropenic fever guidelines</a></span>
              </div>
            </div>
          </div>
          <div class="card">
            <div class="card-header" id="headingTwo">
              <h2 class="mb-0">
                <button class="btn btn-link collapsed btn-penn" type="button" data-toggle="collapse" data-target="#collapseTwo" aria-expanded="false" aria-controls="collapseTwo"><i class="fa fa-plus"></i>
                  Cholecystitis and Cholangitis
                </button>
              </h2>
            </div>
            <div id="collapseTwo" class="collapse" aria-labelledby="headingTwo" data-parent="">
              <div class="card-body">
                <p>Antimicrobial dosing is based on a patient with normal renal function. For dosing based on impaired renal function, see <a href="#">Dosing of Antimicrobial Agents</a>.</p>
                <p>Antimicrobial therapy should be initiated only in patients that fall into the appropriate categories below.</p>
                <p>An appropriate source control procedure is essential to success of treatment (e.g. cholecystostomy, biliary stent, gallstone removal, etc.).</p>
                <p>The following recommendations are empiric guidelines. Base definitive choice of antimicrobial agents on operative cultures and susceptibility test results.</p>
                <p>These guidelines may not be appropriate in patients with history of colonization or infection with resistant organisms or recent antimicrobial exposure. For these patients, consider Infectious Diseases consultation.</p>

                <table class="table table-bordered table-sm table-responsive table-penn">
                  <thead class="thead-dark">
                    <tr>
                      <th scope="col">Setting</th>
                      <th scope="col">Preferred Therapy</th>
                      <th scope="col">&beta;-Lactam Allergy</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td colspan="3" class="tr-penn"><strong>Community-acquired acute cholecystitis</strong> <br>
                        Hospitalized &lt; 48 hrs <br>
                        <i>Enterobacteriaceae,
                          Streptococcus spp. +/-
                          Anaerobes </i></td>
                    </tr>
                    <tr>
                      <th scope="row">No signs or symptoms of infection <br><i>WBC ≤ 12.5, temp. ≤ 38.5°C, no radiographic signs of rupture, abscess, or gas</i></th>
                      <td colspan="2">No antibiotics necessary.</td>
                    </tr>
                    <tr>
                      <th scope="row">Mild to moderate severity</th>
                      <td>Ceftriaxone 1 gram IV daily</td>
                      <td>Levofloxacin 500 mg IV/PO daily</td>
                    </tr>
                    <tr>
                      <th scope="row">High risk <br> <i>Adv. age, immuno-compromised<sup>1</sup></i></th>
                      <td>Cefepime 1 gram IV Q8H <b>AND</b> Metronidazole 500 mg IV/PO Q12H <br> <b>Alternative:</b> Piperacillin-tazobactam 4.5 grams IV Q8H</td>
                      <td>Levofloxacin 750 mg IV/PO daily <b>AND</b> Metronidazole 500 mg PO Q12H</td>
                    </tr>
                    <tr>
                      <th scope="row">High severity <br> <i>Sepsis, septic shock</i></th>
                      <td colspan="2"><a href="#">See sepsis/septic shock guidelines</a></td>
                    </tr>
                    <tr class="tr-penn">
                      <td colspan="3"><strong>Community-acquired cholangitis</strong> <br> Hospitalized &lt; 48 hrs <br>
                        <i>Enterobacteriaceae,
                          Streptococcus spp.</i></td>
                    </tr>
                    <tr>
                      <th scope="row">All</th>
                      <td>Ceftriaxone 1 gram IV daily <br><b>Alternative: </b>Ampicillin/sulbactam 1.5 grams IV Q6H</td>
                      <td>Levofloxacin 750 mg IV/PO daily</td>
                    </tr>
                    <tr class="tr-penn">
                      <td colspan="3"><strong>Healthcare-associated biliary infection</strong><br> Hospitalized ≥ 48 hrs, Post-operative <br>
                        <i>P. aeruginosa,
                          Enterobacteriaceae,
                          S. aureus,
                          Streptococcus spp.,
                          Enterococcus spp.,
                          Anaerobes</i></td>
                    </tr>
                    <tr>
                      <th scope="row">Non-sepsis</th>
                      <td><b>Option 1:</b> Cefepime 1 gram IV Q8H <b>AND</b> Metronidazole 500 mg PO Q12H <b>AND</b> Vancomycin IV (<a href="#">dosing</a>) <br>
                        <b>Option 2: </b>Piperacillin/tazobactam 4.5 grams IV Q8H <b>AND</b> Vancomycin IV (<a href="#">dosing</a>)</td>
                      <td>Levofloxacin 750 mg IV/PO daily <b>AND</b> Metronidazole 500 mg PO Q12H <b>AND</b> Vancomycin IV</td>
                    </tr>
                    <tr>
                      <th scope="row">Sepsis/septic shock</th>
                      <td colspan="2"><a href="#">
                          See Sepsis/Septic Shock Guidelines</a></td>
                    </tr>
                  </tbody>
                </table>
                <span class="table-subtext"><sup>1</sup>For patients with neutropenia, refer to the <a href="#">Neutropenic fever guidelines</a></span>
              </div>
            </div>
          </div>
          <div class="card">
            <div class="card-header" id="headingThree">
              <h2 class="mb-0">
                <button class="btn btn-link collapsed btn-penn" type="button" data-toggle="collapse" data-target="#collapseThree" aria-expanded="false" aria-controls="collapseThree"><i class="fa fa-plus"></i>
                  Necrotizing Pancreatitis
                </button>
              </h2>
            </div>
            <div id="collapseThree" class="collapse" aria-labelledby="headingThree" data-parent="">
              <div class="card-body">
                <p>Antimicrobial dosing is based on a patient with normal renal function. For dosing based on impaired renal function, see <a href="#">Dosing of Antimicrobial Agents</a>.</p>
                <p>In the setting of infected pancreatitis, an appropriate source control procedure is essential to success of treatment</p>

                <p>The following recommendations are empiric guidelines. Base definitive choice of antimicrobial agents on operative cultures and susceptibility test results.</p>
                <p>These guidelines may not be appropriate in patients with history of colonization or infection with resistant organisms or recent antimicrobial exposure. For these patients, consider Infectious Diseases consultation.</p>

                <table class="table table-bordered table-sm table-responsive table-penn">
                  <thead class="thead-dark">
                    <tr>
                      <th scope="col">Setting</th>
                      <th scope="col">Preferred Therapy</th>
                      <th scope="col">&beta;-Lactam Allergy</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td colspan="3" class="tr-penn"><strong>Necrotizing Pancreatitis</strong> <br>
                        <i>P. aerguinosa, Enterobacteriaceae, Staphylococcus spp., Streptococcus spp., Enterococcus spp., Anaerobes</i></td>
                    </tr>
                    <tr>
                      <th scope="row">No signs or symptoms of infection <br><i>WBC ≤ 12.5, temp. ≤ 38.5°C, no radiographic signs of rupture, abscess, or gas</i></th>
                      <td colspan="2">No antibiotics necessary.</td>
                    </tr>
                    <tr>
                      <th scope="row">Infected Necrotizing Pancreatitis <i>Community Acquired Hospitalized &lt; 48 hrs</i></th>
                      <td><b>Option 1: </b>Piperacillin-tazobactam 4.5 grams IV Q8H <br>
                        <b>Option 2: </b>Cefepime 1 gram IV Q8H <b>AND</b> Metronidazole 500 mg PO Q12H</td>
                      <td>Levofloxacin 750 mg PO daily <b>AND</b> Metronidazole 500 mg PO Q12H <b>AND</b> Vancomycin IV (<a href="#">dosing</a>)</td>
                    </tr>
                    <tr>
                      <th scope="row">Infected Necrotizing Pancreatitis <i>Healthcare Associated Hospitalized &ge; 48 hrs</i></th>
                      <td><b>Option 1:</b> Cefepime 1 gram IV Q8H <b>AND</b> Metronidazole 500 mg PO Q12H <b>AND</b> Vancomycin IV (<a href="#">dosing</a>) <br>
                        <b>Option 2:</b> Piperacillin/tazobactam 4.5 grams IV Q8H <b>AND</b> Vancomycin IV (<a href="#">dosing</a>)</td>
                      <td>Levofloxacin 750 mg IV/PO daily <b>AND</b> Metronidazole 500 mg PO Q12H <b>AND</b> Vancomycin IV (<a href="#">dosing</a>)</td>
                    </tr>

                  </tbody>
                </table>
              </div>
            </div>
          </div>
          <div class="card">
            <div class="card-header" id="headingFive">
              <h2 class="mb-0">
                <button class="btn btn-link collapsed btn-penn" type="button" data-toggle="collapse" data-target="#collapseFive" aria-expanded="false" aria-controls="collapseFive"><i class="fa fa-plus"></i>
                  Duration of Therapy and Definitive Treatment
                </button>
              </h2>
            </div>
            <div id="collapseFive" class="collapse" aria-labelledby="headingFive" data-parent="">
              <div class="card-body">
                <p>Antimicrobial therapy of established intra-abdominal infection should be limited to <b>5 days in most patients</b>, unless it is difficult to achieve adequate source control</p>
                <ul>
                  <li>When signs and symptoms of infection are resolved, no further antibiotic therapy is typically required</li>
                  <li>In patients who have persistent or recurrent clinical evidence of intra-abdominal infection after 5 days of therapy, appropriate diagnostic investigation should be undertaken (usually cross-sectional imaging with CT or MRI)</li>
                  <li>Extra-abdominal sources of infection and non-infectious inflammatory conditions should also be investigated if the patient is not experiencing a satisfactory clinical response to an appropriate empiric antimicrobial regimen initial empiric antimicrobial regimen
                  </li>
                </ul>
                <p>Patients who have undergone <b>cholecystectomy for acute cholecystitis</b> should have antimicrobial therapy discontinued within 24 hours unless there is evidence of infection outside the wall of the gallbladder</p>
                <p><b>Bowel injuries</b> attributable to penetrating, blunt, or iatrogenic trauma that are repaired within 12 hours and any other intraoperative contamination of the operative field by enteric contents should be treated with antibiotics for ≤ 24 hours</p>
                <p><b>Acute appendicitis</b> without evidence of perforation, abscess, or local peritonitis requires only prophylactic administration of narrow spectrum regimens active against aerobic and facultative and obligate anaerobes (e.g. ceftriaxone 1 gram IV daily and metronidazole 500 mg PO or IV Q12H). Treatment should be discontinued within 24 hours.</p>
                <p>If culture and susceptibility testing identify organisms that are only susceptible to intravenous therapy, this therapy should be continued as an outpatient to finish the course. For patients recovering from intra-abdominal infection, completion of a course with oral antibiotics is acceptable in patients able to tolerate an oral diet.</p>
              </div>
            </div>
          </div>
          <div class="card">
            <div class="card-header" id="headingFour">
              <h2 class="mb-0">
                <button class="btn btn-link collapsed btn-penn" type="button" data-toggle="collapse" data-target="#collapseFour" aria-expanded="false" aria-controls="collapseFour"><i class="fa fa-plus"></i>
                  References
                </button>
              </h2>
            </div>
            <div id="collapseFour" class="collapse" aria-labelledby="headingFour" data-parent="">
              <div class="card-body">
                <ul>
                  <li><a href="http://www.ncbi.nlm.nih.gov/pubmed/20034345">Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 133-64.</a></li>
                  <li><a href="http://www.ncbi.nlm.nih.gov/pubmed/25005651">Regimbeau JM, Fuks D, Pautrat K, et al., for the FRENCH Study Group. Effect of postoperative antibiotic administration on postoperative infection following cholecystectomy for acute calculous cholecystitis: a randomized clinical trial. JAMA 2014; 312: 145-54.</a></li>
                  <li><a href="http://www.ncbi.nlm.nih.gov/pubmed/28085573">Mazuki JE, Tessier JM, May AK, et al. The surgical infection society revised guidelines on the management of intra-abdominal infection. Surgical infections 2017; 18: 1-76</a></li>
                  <li><a href="http://www.ncbi.nlm.nih.gov/pubmed/25992746">Sawyer RG, Claridge JA, Nathens AB et al. Trial of short-course antimicrobial therapy for intraabdominal infection. NEJM 2015; 372: 1996-2005</a></li>
                </ul>
              </div>
            </div>
          </div>
        </div>
        <br>
        <p>Last updated October 9, 2018</p>
      </article>
    </div>



  </div>

  <!-- FOOTER -->
  <footer class="footer-penn">
    Penn Medicine, Philadelphia, PA 800-789-PENN © 2020, The Trustees of the University of Pennsylvania
  </footer>

  <!-- Optional JavaScript -->
  <!-- jQuery first, then Popper.js, then Bootstrap JS -->
  <script src="https://code.jquery.com/jquery-3.5.1.slim.min.js" integrity="sha384-DfXdz2htPH0lsSSs5nCTpuj/zy4C+OGpamoFVy38MVBnE+IbbVYUew+OrCXaRkfj" crossorigin="anonymous"></script>
  <script src="https://cdn.jsdelivr.net/npm/popper.js@1.16.0/dist/umd/popper.min.js" integrity="sha384-Q6E9RHvbIyZFJoft+2mJbHaEWldlvI9IOYy5n3zV9zzTtmI3UksdQRVvoxMfooAo" crossorigin="anonymous"></script>
  <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.5.0/js/bootstrap.min.js" integrity="sha384-OgVRvuATP1z7JjHLkuOU7Xw704+h835Lr+6QL9UvYjZE3Ipu6Tp75j7Bh/kR0JKI" crossorigin="anonymous"></script>
  <!-- Font Awesome icon script -->
  <script>
    $(document).ready(function() {
      // Add minus icon for collapse element which is open by default
      $(".collapse.show").each(function() {
        $(this).prev(".card-header").find(".fa").addClass("fa-minus").removeClass("fa-plus");
      });

      // Toggle plus minus icon on show hide of collapse element
      $(".collapse").on('show.bs.collapse', function() {
        $(this).prev(".card-header").find(".fa").removeClass("fa-plus").addClass("fa-minus");
      }).on('hide.bs.collapse', function() {
        $(this).prev(".card-header").find(".fa").removeClass("fa-minus").addClass("fa-plus");
      });
    });
  </script>
</body></html>